pentoxifylline has been researched along with HIV in 2 studies
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mole, L | 1 |
| Margolis, D | 1 |
| Ghotbi, L | 1 |
| Holodniy, M | 1 |
| Dezube, BJ | 1 |
| Pardee, AB | 1 |
| Chapman, B | 1 |
| Beckett, LA | 1 |
| Korvick, JA | 1 |
| Novick, WJ | 1 |
| Chiurco, J | 1 |
| Kasdan, P | 1 |
| Ahlers, CM | 1 |
| Ecto, LT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS[NCT00000646] | Phase 1 | 54 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for pentoxifylline and HIV
| Article | Year |
|---|---|
The use of pentoxifylline alone in HIV-infected patients.
Topics: CD4-Positive T-Lymphocytes; HIV; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Leuk | 1994 |
1 other study available for pentoxifylline and HIV
| Article | Year |
|---|---|
Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; beta 2-Microglobulin; Biopterins; Body Weight; CD4-Positi | 1993 |